Martin Anlauf
- Epidemiology top 0.5%
- Oncology top 1%
- Neurology top 0.5%
- Surgery top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Co-authors
- Günter KlöppelAurel PerrenEberhard WeihePaul KomminothBertram WiedenmannÉric BaudinLee E. EidenAnne Couvelard
- Topics
- Neuroendocrine Tumor Research Advances (61 papers)Lung Cancer Research Studies (34 papers)Neuroblastoma Research and Treatments (30 papers)
- Cited by
- NeurologyOncologyEpidemiology
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Martin Anlauf
91 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Epidemiology 3.0k
- Oncology 2.7k
- Neurology 2.0k
- Surgery 942
- Endocrinology, Diabetes and Metabolism 497
Countries citing papers authored by Martin Anlauf
This map shows the geographic impact of Martin Anlauf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Anlauf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Anlauf more than expected).
Fields of papers citing papers by Martin Anlauf
This network shows the impact of papers produced by Martin Anlauf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Anlauf. The network helps show where Martin Anlauf may publish in the future.
Co-authorship network of co-authors of Martin Anlauf
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Anlauf. A scholar is included among the top collaborators of Martin Anlauf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Anlauf. Martin Anlauf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 11 | |
| 3 | ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomasbreakdown → | 403 |
| 4 | 21 | |
| 5 | 8 | |
| 6 | 26 | |
| 7 | 54 | |
| 8 | 83 | |
| 9 | 16 | |
| 10 | 80 | |
| 11 | 105 | |
| 12 | 98 | |
| 13 | 58 | |
| 14 | 58 | |
| 15 | 24 | |
| 16 | 83 | |
| 17 | 89 | |
| 18 | 17 | |
| 19 | 47 | |
| 20 | 8 |
About Martin Anlauf
Martin Anlauf is a scholar working on Neurology, Oncology and Epidemiology, having authored 92 papers that have together received 4.3k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (61 papers), Lung Cancer Research Studies (34 papers) and Neuroblastoma Research and Treatments (30 papers). The work is most often cited by research in Neurology (2.0k citations), Oncology (2.7k citations) and Epidemiology (3.0k citations). Martin Anlauf has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Günter Klöppel, Aurel Perren, Eberhard Weihe, Paul Komminoth, Bertram Wiedenmann, Éric Baudin, Lee E. Eiden, Anne Couvelard, Martin Schäfer and Wolfram Trudo Knoefel. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.